The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.
Daily voice recordings reveal early signs of asthma and COPD exacerbations, suggesting voice analysis could enhance remote ...
Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.